Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital

Infection

Volumn 34, Issue 5, 2006, Pages 252-257

  Ye, Y ^a   Li, J B ^a   Ye, D Q ^a   Jiang, Z J ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM DERIVATIVE; CEFALOTIN; CEFEPIME; CEFOPERAZONE; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MONOBACTAM DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CHILD; CHINESE; CLINICAL FEATURE; ENTEROBACTER; ENTEROBACTER CLOACAE; ENTEROBACTER INFECTION; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; UNIVARIATE ANALYSIS; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS;

EID: 33749860787     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-006-5038-3     Document Type: Article

References (20)

1. Kaye KS, Cosgrove S, Harris A, Eliopoulos GM, Carmeli Y: Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. Antimicrob Agents Chemother 2001; 45: 2628-2630.
2. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing: ninth informational supplement M100-S9. NCCLS, Wayne, PA 1995.
3. Anatoliotaki M, Valatas V, Mantadakis E, Apostolakou H, Mavroudis D, Georgoulias V, Rolston KV, Kontoyiannis DP, Galanakis E, Samonis G: Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome. Infection 2004; 32: 56-71.
4. Gallagher PG: Enterobacter bacteremia in pediatric patients. Rev Infect Dis 1990; 12: 808-812.
5. Velasco E, Byington R, Martins CS, Schirmer M, Dias LC, Goncalves V: Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects. Clin Microbiol Infect 2004; 10: 542-549.
6. Gupta N, Aparna, Choudhary U, Garg N, Arora DR: Enterobacter bacteremia. J Assoc Physicians India 2003; 51: 669-672.
7. Velasco E, Soares M, Byington R, Martins CA, Schirmer M, Dias LM, Goncalves VM: Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in adult surgical cancer patients. Eur J Clin Microbiol Infect Dis 2004; 23: 596-602.
8. Pawar M, Mehta Y, Kapoor P, Sharma J, Gupta A, Trehan N: Central venous catheter-related blood stream infections: incidence, risk factors, outcome, and associated pathogens. J Cardiothorac Vasc Anesth 2004; 18: 304-308.
9. Hanna H, Afif C, Alakech B, Boktour M, Tarrand J, Hachem R, Raad I: Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse. Infect Control Hosp Epidemiol 2004; 25: 646-649.
10. Lee SO, Kim YS, Kim BN, Kim MN, Woo JH, Ryu J: Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with Enterobacter bacteremia. Eur J Clin Microbiol Infect Dis 2002; 21: 577-581.
11. Bouza E, Garcia de la Torre M, Erice A, Loza E, Diaz-Borrego J.M, Buzon L: Enterobacter bacteremia. An analysis of 50 episodes. Arch Intern Med 1985; 145: 1024-1027.
12. Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, Ramphal R, Wagener MM, Miyashiro DK, Yu VL: Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115: 585-590.
13. Plonczynski DJ: Wise use of perioperative antibiotics. AORN J 2005; 81: 1260, 1264-1268, 1271-1272; quiz 1275-1278.
14. Sanders W-J, Sanders CC: Enterobacter spp.: pathogens poised to flourish at the turn of the century. Clin Microbiol Rev 1997; 10: 220-241.
15. Jalaluddin S, Devaster J-M, Scheen R, Gerard M, Butzler J-P: Molecular Epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian hospital. J Clin Microbiol 1998; 36: 1846-1852.
16. Wendt C, Lin D, von Baum H: Risk factors for colonization with third-generation cephalosporin-resistant Enterobacteriaceae. Infection 2005; 33: 327-332.
17. Wang FD, Lin ML, Liu CY: Bacteremia in patients with hematological malignancies. Chemotherapy 2005; 51: 147-153.
18. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW: Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005; 49: 760-766.
19. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Oh MD, Kim EC, Choe KW: Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. Clin Infect Dis 2004; 39: 812-818.
20. Perencevich EN: Excess shock and mortality in Staphylococcus aereus related to methicillin resistance. Clin Infect Dis 2000; 31: 1311-1313.